ChengDa Pharmaceuticals Co. Ltd. Cash Flow Reinvestment Rate
ChengDa Pharmaceuticals Co. Ltd. cash flow reinvestment rate. ChengDa Pharmaceuticals Co. Ltd. (301201) has a Cash Flow Reinvestment Rate of 11.85x as of December 2025, reinvesting CN¥403.22 Million (capex CN¥69.02 Million plus investments CN¥334.20 Million) from operating cash flow of CN¥34.02 Million. See ChengDa Pharmaceuticals Co. Ltd. free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of ChengDa Pharmaceuticals Co. Ltd. (2019–2025)
Cash flow reinvestment rate of ChengDa Pharmaceuticals Co. Ltd. from 2019 to 2025. Historical reinvestment intensity for ChengDa Pharmaceuticals Co. Ltd. across 7 annual periods. Explore debt repayment capacity of ChengDa Pharmaceuticals Co. Ltd. to assess how comfortably operating cash covers total debt obligations.
ChengDa Pharmaceuticals Co. Ltd. Cash Flow Reinvestment Rate by Year (2019–2025)
ChengDa Pharmaceuticals Co. Ltd. cash flow reinvestment rate by year from 2019 to 2025. Year-by-year capital reinvestment analysis for ChengDa Pharmaceuticals Co. Ltd.. For the full cash flow conversion analysis, see ChengDa Pharmaceuticals Co. Ltd. cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 11.85x | CN¥403.22 Million | CN¥34.02 Million | CN¥69.02 Million | ▼ -72.0% |
| 2024 | 42.29x | CN¥1.21 Billion | CN¥28.65 Million | CN¥286.36 Million | ▲ +678.6% |
| 2023 | 5.43x | CN¥1.04 Billion | CN¥192.07 Million | CN¥224.67 Million | ▼ -78.3% |
| 2022 | 25.06x | CN¥1.19 Billion | CN¥47.67 Million | CN¥205.69 Million | ▲ +651.3% |
| 2021 | 3.34x | CN¥277.28 Million | CN¥83.14 Million | CN¥138.70 Million | ▲ +481.4% |
| 2020 | 0.57x | CN¥73.99 Million | CN¥128.97 Million | CN¥63.81 Million | ▼ -60.8% |
| 2019 | 1.46x | CN¥98.73 Million | CN¥67.52 Million | CN¥51.06 Million | — |